Maciej Czerwiński

4.7k total citations · 1 hit paper
22 papers, 4.1k citations indexed

About

Maciej Czerwiński is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Maciej Czerwiński has authored 22 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pharmacology. Recurrent topics in Maciej Czerwiński's work include Pharmacogenetics and Drug Metabolism (8 papers), Glutathione Transferases and Polymorphisms (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Maciej Czerwiński is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Glutathione Transferases and Polymorphisms (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Maciej Czerwiński collaborates with scholars based in United States, Israel and Hungary. Maciej Czerwiński's co-authors include Michael R. Boyd, Joseph G. Mayo, Betty J. Abbott, Anne Monks, Michael C. Alley, Dominic A. Scudiero, Miriam L. Hursey, Robert H. Shoemaker, Donald L. Fine and John T. Slattery and has published in prestigious journals such as Nature Communications, JNCI Journal of the National Cancer Institute and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Maciej Czerwiński

22 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

1988 2.8k citations Michael C. Alley, Dominic A. Scudiero et al. PubMed profile →

Peers

Countries citing papers authored by Maciej Czerwiński

Since Specialization

Citations

This map shows the geographic impact of Maciej Czerwiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maciej Czerwiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maciej Czerwiński more than expected).

Fields of papers citing papers by Maciej Czerwiński

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maciej Czerwiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maciej Czerwiński. The network helps show where Maciej Czerwiński may publish in the future.

Co-authorship network of co-authors of Maciej Czerwiński

This figure shows the co-authorship network connecting the top 25 collaborators of Maciej Czerwiński. A scholar is included among the top collaborators of Maciej Czerwiński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maciej Czerwiński. Maciej Czerwiński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hyaluronan synthesis inhibition normalizes ethanol‐enhanced hepatic stellate cell activation 2023 ·Alcohol Clinical and Experimental Research ·(unknown), (unknown), (unknown), (unknown), (unknown), Sarah E. Tague, Maciej Czerwiński, Katie Dennis, Michele T. Pritchard	4
2	In vitro evaluation suggests fenfluramine and norfenfluramine are unlikely to act as perpetrators of drug interactions 2022 ·Pharmacology Research & Perspectives ·(unknown), Maciej Czerwiński, Pallavi B. Limaye, Brian W. Ogilvie, (unknown), Ben J. Boyd	15
3	In vitro evaluation of fenfluramine and norfenfluramine as victims of drug interactions 2022 ·Pharmacology Research & Perspectives ·(unknown), Maciej Czerwiński, Pallavi B. Limaye, (unknown), Brian W. Ogilvie, Steven M. Smith, Ben J. Boyd	16
4	An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis 2020 ·Nature Communications ·Yifeng Wang, Sumedha Gunewardena, Feng Li, David Matye, Cheng Chen, Xiaojuan Chao, (unknown), Yuxia Zhang, Maciej Czerwiński, Hong‐Min Ni, Wen‐Xing Ding, Tiangang Li	77
5	Microsomal cytochrome P450 enzyme activities in nonalcoholic steatohepatitis livers 2019 ·Drug Metabolism and Pharmacokinetics ·Maciej Czerwiński, (unknown), (unknown), (unknown), (unknown), (unknown), Frédérique Yiannikouris, (unknown), Brian W. Ogilvie	1
6	Direct and cytokine‐mediated effects of albumin‐fused growth hormone,TV‐1106, onCYPenzyme expression in human hepatocytes in vitro 2018 ·Pharmacology Research & Perspectives ·Maciej Czerwiński, (unknown), (unknown), Hussein Hallak, (unknown), (unknown), (unknown), Merav Bassan	6
7	Membrane Assays to Characterize Interaction of Drugs with ABCB1 2015 ·The Journal of Membrane Biology ·(unknown), (unknown), Tünde Nagy, Katalin Jakab, (unknown), Katalin Gémes, Krisztina Herédi‐Szabó, Ferenc Fülöp, Gábor K. Tóth, Maciej Czerwiński, (unknown), Péter Krajcsi	9
8	Anti-CD28 Monoclonal Antibody–Stimulated Cytokines Released from Blood Suppress CYP1A2, CYP2B6, and CYP3A4 in Human Hepatocytes In Vitro 2014 ·Drug Metabolism and Disposition ·Maciej Czerwiński, Faraz Kazmi, Andrew Parkinson, David B. Buckley	6
9	Expression of Constitutive Androstane Receptor, Hepatic Nuclear Factor 4α, and P450 Oxidoreductase Genes Determines Interindividual Variability in Basal Expression and Activity of a Broad Scope of Xenobiotic Metabolism Genes in the Human Liver 2007 ·Drug Metabolism and Disposition ·Matthew Wortham, Maciej Czerwiński, Lin He, Andrew Parkinson, Yu‐Jui Yvonne Wan	105
10	Effects of Prototypical Microsomal Enzyme Inducers on Cytochrome P450 Expression in Cultured Human Hepatocytes 2003 ·Drug Metabolism and Disposition ·Ajay Madan, Richard Graham, Kathleen Carroll, Daniel R. Mudra, (unknown), (unknown), (unknown), Maciej Czerwiński, Jameson Forster, Maria Ribadeneira, Liang‐Shang Gan, Edward L. LeCluyse, Karl Zech, Philmore Robertson, Patrick Koch, Lida Antonian, (unknown), Yu Li, Andrew Parkinson	276
11	Analysis of CYP mRNA expression by branched DNA technology 2002 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Maciej Czerwiński, (unknown), Ajay Madan, K. K. Carroll, Daniel R. Mudra, Lawrence L. Gan, Gang Luo, Andrew Parkinson	10
12	Human CD34+ cells do not express glutathione S-transferases alpha 1997 ·Gene Therapy ·Maciej Czerwiński, HP Kiem, (unknown)	15
13	Busulfan-glutathione conjugation catalyzed by human liver cytosolic glutathione S-transferases. 1996 ·PubMed ·John P. Gibbs, Maciej Czerwiński, John T. Slattery	75
14	Busulfan conjugation by glutathione S-transferases alpha, mu, and pi. 1996 ·Drug Metabolism and Disposition ·Maciej Czerwiński, John P. Gibbs, John T. Slattery	120
15	Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. 1994 ·PubMed ·Maciej Czerwiński, Theodore L. McLemore, H V Gelboin, Frank J. Gonzalez	81
16	Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism. 1991 ·PubMed ·Maciej Czerwiński, Theodore L. McLemore, R.M. Philpot, Patson T. Nhamburo, Ken Korzekwa, Harry V. Gelboin, Frank J. Gonzalez	63
17	Metabolic Activation of 4-Ipomeanol in Human Lung, Primary Pulmonary Carcinomas, and Established Human Pulmonary Carcinoma Cell Lines 1990 ·JNCI Journal of the National Cancer Institute ·Theodore L. McLemore, Charles L. Litterst, Bruno Coudert, M. C. Liu, Walter C. Hubbard, S. Adelberg, Maciej Czerwiński, (unknown), J. Eggleston, Michael R. Boyd	23
18	Expression of CYP1A1 Gene in Patients With Lung Cancer: Evidence for Cigarette Smoke-Induced Gene Expression in Normal Lung Tissue and for Altered Gene Regulation in Primary Pulmonary Carcinomas 1990 ·JNCI Journal of the National Cancer Institute ·Theodore L. McLemore, S. Adelberg, M. C. Liu, (unknown), (unknown), Walter C. Hubbard, Maciej Czerwiński, Thomas G. Wood, Ritsa Storeng, (unknown), J. Eggleston, Michael R. Boyd, Ronald N. Hines	289
19	Altered Regulation of the Cytochrome P4501A1 Gene: Novel Inducer-Independent Gene Expression in Pulmonary Carcinoma Cell Lines 1989 ·JNCI Journal of the National Cancer Institute ·Theodore L. McLemore, S. Adelberg, Maciej Czerwiński, Walter C. Hubbard, (unknown), Ritsa Storeng, Thomas G. Wood, Ronald N. Hines, Michael R. Boyd	28
20	Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. breakdown → 1988 ·PubMed ·Michael C. Alley, Dominic A. Scudiero, Anne Monks, Miriam L. Hursey, Maciej Czerwiński, Donald L. Fine, Betty J. Abbott, Joseph G. Mayo, Robert H. Shoemaker, Michael R. Boyd	2841

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact